|
|
|
Insider
Information: |
Bienaime Jean Jacques |
Relationship: |
|
City: |
Palo Alto |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
7 |
|
Direct
Shares |
539,854 |
|
Indirect Shares
|
247,533 |
|
|
Direct
Value |
$43,079,680 |
|
|
Indirect Value
|
$21,938,850 |
|
|
Total
Shares |
787,387 |
|
|
Total
Value |
$65,018,530 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
2
|
1
|
Stock
price went up :
|
1
|
0
|
Stock
price went down : |
1
|
1
|
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
Percentage
Gain/Loss : |
-13.1%
|
-5.5%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Biomarin Pharmaceutical Inc |
BMRN |
Director |
2024-05-20 |
473,792 |
2024-05-20 |
247,533 |
Premium* |
|
Neurogesx Inc |
NGSX |
Director |
2011-07-26 |
21,748 |
|
0 |
Premium* |
|
InterMune Inc |
ITMN |
Director |
2014-09-29 |
0 |
2012-04-06 |
0 |
Premium* |
|
Portola Pharmaceuticals Inc |
PTLA |
Director |
2014-05-16 |
706 |
2013-05-28 |
0 |
Premium* |
|
Immunic Inc |
IMUX |
Director |
2018-09-24 |
18,500 |
2001-04-23 |
0 |
Premium* |
|
Incyte Corp |
INCY |
Director |
2023-06-14 |
15,493 |
|
0 |
Premium* |
|
Immunome Inc. |
IMNM |
|
2024-05-21 |
9,615 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
852 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 20 of 35
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2007-09-19 |
4 |
OE |
$6.46 |
$64,600 |
D/D |
10,000 |
16,695 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2007-09-25 |
4 |
OE |
$6.46 |
$64,600 |
D/D |
10,000 |
16,695 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2007-09-28 |
4 |
OE |
$6.46 |
$124,077 |
D/D |
19,207 |
25,902 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2007-10-01 |
4 |
OE |
$6.46 |
$5,123 |
D/D |
793 |
26,695 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2007-12-17 |
4 |
OE |
$6.46 |
$96,900 |
D/D |
15,000 |
22,213 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2008-01-02 |
4 |
OE |
$6.46 |
$96,900 |
D/D |
15,000 |
22,213 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2008-02-29 |
4 |
OE |
$6.46 |
$116,280 |
D/D |
18,000 |
25,213 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2008-03-03 |
4 |
OE |
$6.46 |
$12,920 |
D/D |
2,000 |
27,213 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2008-03-04 |
4 |
OE |
$6.46 |
$25,840 |
D/D |
4,000 |
31,213 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2008-05-01 |
4 |
OE |
$6.46 |
$32,300 |
D/D |
5,000 |
11,120 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2008-05-02 |
4 |
OE |
$6.46 |
$64,600 |
D/D |
10,000 |
21,120 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2008-05-05 |
4 |
OE |
$6.46 |
$32,300 |
D/D |
5,000 |
26,120 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2008-05-09 |
4 |
OE |
$6.46 |
$51,680 |
D/D |
8,000 |
11,567 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2008-05-12 |
4 |
OE |
$6.46 |
$32,300 |
D/D |
5,000 |
16,567 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2008-05-15 |
4 |
OE |
$6.46 |
$32,300 |
D/D |
5,000 |
8,567 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2008-06-05 |
4 |
OE |
$6.46 |
$19,380 |
D/D |
3,000 |
6,567 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Office |
|
2008-08-06 |
4 |
OE |
$6.46 |
$3,876 |
D/D |
600 |
9,167 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Office |
|
2008-08-07 |
4 |
OE |
$6.46 |
$3,230 |
D/D |
500 |
9,667 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2008-08-08 |
4 |
OE |
$6.46 |
$4,199 |
D/D |
650 |
10,317 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2008-08-11 |
4 |
OE |
$6.46 |
$3,876 |
D/D |
600 |
10,917 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2009-06-22 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,500 |
59,440 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2010-01-26 |
4 |
OE |
$19.75 |
$49,375 |
D/D |
2,500 |
47,940 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2010-05-22 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,500 |
94,067 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2010-06-07 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,000 |
99,067 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2010-08-30 |
4 |
OE |
$6.46 |
$19,380 |
D/D |
3,000 |
102,067 |
0 |
- |
|
852 Records found
|
|
Page 20 of 35 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|